Literature DB >> 32315032

Systematic in vitro profiling of off-target affinity, cleavage and efficiency for CRISPR enzymes.

Liyang Zhang1,2, H Tomas Rube3,4,5, Christopher A Vakulskas2, Mark A Behlke2, Harmen J Bussemaker4,5, Miles A Pufall1.   

Abstract

CRISPR RNA-guided endonucleases (RGEs) cut or direct activities to specific genomic loci, yet each has off-target activities that are often unpredictable. We developed a pair of simple in vitro assays to systematically measure the DNA-binding specificity (Spec-seq), catalytic activity specificity (SEAM-seq) and cleavage efficiency of RGEs. By separately quantifying binding and cleavage specificity, Spec/SEAM-seq provides detailed mechanistic insight into off-target activity. Feature-based models generated from Spec/SEAM-seq data for SpCas9 were consistent with previous reports of its in vitro and in vivo specificity, validating the approach. Spec/SEAM-seq is also useful for profiling less-well characterized RGEs. Application to an engineered SpCas9, HiFi-SpCas9, indicated that its enhanced target discrimination can be attributed to cleavage rather than binding specificity. The ortholog ScCas9, on the other hand, derives specificity from binding to an extended PAM. The decreased off-target activity of AsCas12a (Cpf1) appears to be primarily driven by DNA-binding specificity. Finally, we performed the first characterization of CasX specificity, revealing an all-or-nothing mechanism where mismatches can be bound, but not cleaved. Together, these applications establish Spec/SEAM-seq as an accessible method to rapidly and reliably evaluate the specificity of RGEs, Cas::gRNA pairs, and gain insight into the mechanism and thermodynamics of target discrimination.
© The Author(s) 2020. Published by Oxford University Press on behalf of Nucleic Acids Research.

Entities:  

Mesh:

Substances:

Year:  2020        PMID: 32315032      PMCID: PMC7229833          DOI: 10.1093/nar/gkaa231

Source DB:  PubMed          Journal:  Nucleic Acids Res        ISSN: 0305-1048            Impact factor:   16.971


  59 in total

1.  Genome-wide analysis reveals characteristics of off-target sites bound by the Cas9 endonuclease.

Authors:  Cem Kuscu; Sevki Arslan; Ritambhara Singh; Jeremy Thorpe; Mazhar Adli
Journal:  Nat Biotechnol       Date:  2014-05-18       Impact factor: 54.908

2.  Rationally engineered Cas9 nucleases with improved specificity.

Authors:  Ian M Slaymaker; Linyi Gao; Bernd Zetsche; David A Scott; Winston X Yan; Feng Zhang
Journal:  Science       Date:  2015-12-01       Impact factor: 47.728

3.  Cofactor binding evokes latent differences in DNA binding specificity between Hox proteins.

Authors:  Matthew Slattery; Todd Riley; Peng Liu; Namiko Abe; Pilar Gomez-Alcala; Iris Dror; Tianyin Zhou; Remo Rohs; Barry Honig; Harmen J Bussemaker; Richard S Mann
Journal:  Cell       Date:  2011-12-09       Impact factor: 41.582

4.  A machine learning approach for predicting CRISPR-Cas9 cleavage efficiencies and patterns underlying its mechanism of action.

Authors:  Shiran Abadi; Winston X Yan; David Amar; Itay Mayrose
Journal:  PLoS Comput Biol       Date:  2017-10-16       Impact factor: 4.475

5.  New CRISPR-Cas systems from uncultivated microbes.

Authors:  David Burstein; Lucas B Harrington; Steven C Strutt; Alexander J Probst; Karthik Anantharaman; Brian C Thomas; Jennifer A Doudna; Jillian F Banfield
Journal:  Nature       Date:  2016-12-22       Impact factor: 49.962

6.  Structural insights into DNA cleavage activation of CRISPR-Cas9 system.

Authors:  Cong Huai; Gan Li; Ruijie Yao; Yingyi Zhang; Mi Cao; Liangliang Kong; Chenqiang Jia; Hui Yuan; Hongyan Chen; Daru Lu; Qiang Huang
Journal:  Nat Commun       Date:  2017-11-09       Impact factor: 14.919

7.  CasX enzymes comprise a distinct family of RNA-guided genome editors.

Authors:  Jun-Jie Liu; Natalia Orlova; Benjamin L Oakes; Enbo Ma; Hannah B Spinner; Katherine L M Baney; Jonathan Chuck; Dan Tan; Gavin J Knott; Lucas B Harrington; Basem Al-Shayeb; Alexander Wagner; Julian Brötzmann; Brett T Staahl; Kian L Taylor; John Desmarais; Eva Nogales; Jennifer A Doudna
Journal:  Nature       Date:  2019-02-04       Impact factor: 49.962

8.  High-throughput profiling of off-target DNA cleavage reveals RNA-programmed Cas9 nuclease specificity.

Authors:  Vikram Pattanayak; Steven Lin; John P Guilinger; Enbo Ma; Jennifer A Doudna; David R Liu
Journal:  Nat Biotechnol       Date:  2013-08-11       Impact factor: 54.908

9.  Multiplexed activation of endogenous genes by CRISPR-on, an RNA-guided transcriptional activator system.

Authors:  Albert W Cheng; Haoyi Wang; Hui Yang; Linyu Shi; Yarden Katz; Thorold W Theunissen; Sudharshan Rangarajan; Chikdu S Shivalila; Daniel B Dadon; Rudolf Jaenisch
Journal:  Cell Res       Date:  2013-08-27       Impact factor: 25.617

10.  Genome-Scale CRISPR-Mediated Control of Gene Repression and Activation.

Authors:  Luke A Gilbert; Max A Horlbeck; Britt Adamson; Jacqueline E Villalta; Yuwen Chen; Evan H Whitehead; Carla Guimaraes; Barbara Panning; Hidde L Ploegh; Michael C Bassik; Lei S Qi; Martin Kampmann; Jonathan S Weissman
Journal:  Cell       Date:  2014-10-09       Impact factor: 41.582

View more
  7 in total

1.  Systematic in vitro specificity profiling reveals nicking defects in natural and engineered CRISPR-Cas9 variants.

Authors:  Karthik Murugan; Shravanti K Suresh; Arun S Seetharam; Andrew J Severin; Dipali G Sashital
Journal:  Nucleic Acids Res       Date:  2021-04-19       Impact factor: 16.971

2.  Efficient Cas9-based Genome Editing Using CRISPR Analysis Webtools in Severe Early-onset-obesity Patient-derived iPSCs.

Authors:  Achchhe Patel; Grazia Iannello; Alejandro Garcia Diaz; Dario Sirabella; Vidhu Thaker; Barbara Corneo
Journal:  Curr Protoc       Date:  2022-08

Review 3.  Tips, Tricks, and Potential Pitfalls of CRISPR Genome Editing in Saccharomyces cerevisiae.

Authors:  Jacob S Antony; John M Hinz; John J Wyrick
Journal:  Front Bioeng Biotechnol       Date:  2022-05-30

4.  Chimeric CRISPR-CasX enzymes and guide RNAs for improved genome editing activity.

Authors:  Connor A Tsuchida; Shouyue Zhang; Mohammad Saffari Doost; Yuqian Zhao; Jia Wang; Elizabeth O'Brien; Huan Fang; Cheng-Ping Li; Danyuan Li; Zhuo-Yan Hai; Jonathan Chuck; Julian Brötzmann; Araz Vartoumian; David Burstein; Xiao-Wei Chen; Eva Nogales; Jennifer A Doudna; Jun-Jie Gogo Liu
Journal:  Mol Cell       Date:  2022-02-25       Impact factor: 19.328

Review 5.  Tools for experimental and computational analyses of off-target editing by programmable nucleases.

Authors:  X Robert Bao; Yidan Pan; Ciaran M Lee; Timothy H Davis; Gang Bao
Journal:  Nat Protoc       Date:  2020-12-07       Impact factor: 13.491

6.  R-loop formation and conformational activation mechanisms of Cas9.

Authors:  Luuk Loeff; Irma Querques; Lena M Muckenfuss; Martin Pacesa; Marta Sawicka; Martin Jinek
Journal:  Nature       Date:  2022-08-24       Impact factor: 69.504

7.  AsCas12a ultra nuclease facilitates the rapid generation of therapeutic cell medicines.

Authors:  Liyang Zhang; John A Zuris; Ramya Viswanathan; Jasmine N Edelstein; Rolf Turk; Bernice Thommandru; H Tomas Rube; Steve E Glenn; Michael A Collingwood; Nicole M Bode; Sarah F Beaudoin; Swarali Lele; Sean N Scott; Kevin M Wasko; Steven Sexton; Christopher M Borges; Mollie S Schubert; Gavin L Kurgan; Matthew S McNeill; Cecilia A Fernandez; Vic E Myer; Richard A Morgan; Mark A Behlke; Christopher A Vakulskas
Journal:  Nat Commun       Date:  2021-06-23       Impact factor: 14.919

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.